Exact Mass: 576.2699349999999
Exact Mass Matches: 576.2699349999999
Found 228 metabolites which its exact mass value is equals to given mass value 576.2699349999999
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Anaerobilin
16alpha-[(6-O-sulfo-beta-D-glucopyranosyl)oxy]pregn-5-ene-3beta,20-diol
1-O-benzoylsalannic acid methyl ester|1-O-decinnamoyl-1-O-benzoylohchinin
Asp Arg Thr Trp
Asp Arg Trp Thr
Asp Thr Arg Trp
Asp Thr Trp Arg
Asp Trp Arg Thr
Asp Trp Thr Arg
Glu Arg Ser Trp
Glu Arg Trp Ser
Glu Ser Arg Trp
Glu Ser Trp Arg
Glu Trp Arg Ser
Glu Trp Ser Arg
Phe Pro Gln Trp
C30H36N6O6 (576.2696195999999)
Phe Pro Trp Gln
C30H36N6O6 (576.2696195999999)
Phe Gln Pro Trp
C30H36N6O6 (576.2696195999999)
Phe Gln Trp Pro
C30H36N6O6 (576.2696195999999)
Phe Trp Pro Gln
C30H36N6O6 (576.2696195999999)
Phe Trp Gln Pro
C30H36N6O6 (576.2696195999999)
Ile Met Gln Trp
Ile Met Trp Gln
Ile Gln Met Trp
Ile Gln Trp Met
Ile Trp Met Gln
Ile Trp Gln Met
Leu Met Gln Trp
Leu Met Trp Gln
Leu Gln Met Trp
Leu Gln Trp Met
Leu Trp Met Gln
Leu Trp Gln Met
Met Ile Gln Trp
Met Ile Trp Gln
Met Leu Gln Trp
Met Leu Trp Gln
Met Gln Ile Trp
Met Gln Leu Trp
Met Gln Trp Ile
Met Gln Trp Leu
Met Trp Ile Gln
Met Trp Leu Gln
Met Trp Gln Ile
Met Trp Gln Leu
Pro Phe Gln Trp
C30H36N6O6 (576.2696195999999)
Pro Phe Trp Gln
C30H36N6O6 (576.2696195999999)
Pro Gln Phe Trp
C30H36N6O6 (576.2696195999999)
Pro Gln Trp Phe
C30H36N6O6 (576.2696195999999)
Pro Trp Phe Gln
C30H36N6O6 (576.2696195999999)
Pro Trp Gln Phe
C30H36N6O6 (576.2696195999999)
Gln Phe Pro Trp
C30H36N6O6 (576.2696195999999)
Gln Phe Trp Pro
C30H36N6O6 (576.2696195999999)
Gln Ile Met Trp
Gln Ile Trp Met
Gln Leu Met Trp
Gln Leu Trp Met
Gln Met Ile Trp
Gln Met Leu Trp
Gln Met Trp Ile
Gln Met Trp Leu
Gln Pro Phe Trp
C30H36N6O6 (576.2696195999999)
Gln Pro Trp Phe
C30H36N6O6 (576.2696195999999)
Gln Trp Phe Pro
C30H36N6O6 (576.2696195999999)
Gln Trp Ile Met
Gln Trp Leu Met
Gln Trp Met Ile
Gln Trp Met Leu
Gln Trp Pro Phe
C30H36N6O6 (576.2696195999999)
Arg Asp Thr Trp
Arg Asp Trp Thr
Arg Glu Ser Trp
Arg Glu Trp Ser
Arg Ser Glu Trp
Arg Ser Trp Glu
Arg Thr Asp Trp
Arg Thr Trp Asp
Arg Trp Asp Thr
Arg Trp Glu Ser
Arg Trp Ser Glu
Arg Trp Thr Asp
Ser Glu Arg Trp
Ser Glu Trp Arg
Ser Arg Glu Trp
Ser Arg Trp Glu
Ser Val Trp Trp
C30H36N6O6 (576.2696195999999)
Ser Trp Glu Arg
Ser Trp Arg Glu
Ser Trp Val Trp
C30H36N6O6 (576.2696195999999)
Ser Trp Trp Val
C30H36N6O6 (576.2696195999999)
Thr Asp Arg Trp
Thr Asp Trp Arg
Thr Arg Asp Trp
Thr Arg Trp Asp
Thr Trp Asp Arg
Thr Trp Arg Asp
Val Ser Trp Trp
C30H36N6O6 (576.2696195999999)
Val Trp Ser Trp
C30H36N6O6 (576.2696195999999)
Val Trp Trp Ser
C30H36N6O6 (576.2696195999999)
Trp Asp Arg Thr
Trp Asp Thr Arg
Trp Glu Arg Ser
Trp Glu Ser Arg
Trp Phe Pro Gln
C30H36N6O6 (576.2696195999999)
Trp Phe Gln Pro
C30H36N6O6 (576.2696195999999)
Trp Ile Met Gln
Trp Ile Gln Met
Trp Leu Met Gln
Trp Leu Gln Met
Trp Met Ile Gln
Trp Met Leu Gln
Trp Met Gln Ile
Trp Met Gln Leu
Trp Pro Phe Gln
C30H36N6O6 (576.2696195999999)
Trp Pro Gln Phe
C30H36N6O6 (576.2696195999999)
Trp Gln Phe Pro
C30H36N6O6 (576.2696195999999)
Trp Gln Ile Met
Trp Gln Leu Met
Trp Gln Met Ile
Trp Gln Met Leu
Trp Gln Pro Phe
C30H36N6O6 (576.2696195999999)
Trp Arg Asp Thr
Trp Arg Glu Ser
Trp Arg Ser Glu
Trp Arg Thr Asp
Trp Ser Glu Arg
Trp Ser Arg Glu
Trp Ser Val Trp
C30H36N6O6 (576.2696195999999)
Trp Ser Trp Val
C30H36N6O6 (576.2696195999999)
Trp Thr Asp Arg
Trp Thr Arg Asp
Trp Val Ser Trp
C30H36N6O6 (576.2696195999999)
Trp Val Trp Ser
C30H36N6O6 (576.2696195999999)
Trp Trp Ser Val
C30H36N6O6 (576.2696195999999)
Trp Trp Val Ser
C30H36N6O6 (576.2696195999999)
POLY[4,4-METHYLENEBIS(PHENYL ISOCYANATE)-ALT-1,4-BUTANEDIOL/POLY(BUTYLENE ADIPATE)]
cyclooctane,(E)-5-hydroxy-2,2,6,6-tetramethylhept-4-en-3-one,ruthenium
C30H50O4Ru (576.2752300000001)
Albuterol sulfate
D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
[(2R,3R,4S,5R,6R)-2-[[(3S,4R,5R,8S,9S,10S,13R,14S,17R)-17-ethenyl-3-hydroxy-10-(hydroxymethyl)-13-methyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-4-yl]oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl] hydrogen sulfate
(4Z,10Z,14E)-8,12-bis(2-carboxyethyl)-3,7,13,18-tetramethyl-1,2,17-trivinyl-23,24-dihydrobilin
(5S,6R,9R)-5-methoxy-N-(2-methoxyphenyl)-3,6,9-trimethyl-2-oxo-14-(pyrazine-2-carbonylamino)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide
C30H36N6O6 (576.2696195999999)
[(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-4-[3-(2-methoxyphenyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridin-6-yl]-(4-methyl-1-piperazinyl)methanone
(5S,6R,9R)-5-methoxy-14-[(4-methoxyphenyl)sulfonylamino]-3,6,9-trimethyl-2-oxo-N-propan-2-yl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide
[(3R)-2-[(R)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-4-[3-(2-methoxyphenyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridin-6-yl]-(4-methyl-1-piperazinyl)methanone
[(3R)-2-tert-butylsulfinyl-3-(2-hydroxyethyl)-4-[3-(3-methoxyphenyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridin-6-yl]-(4-methyl-1-piperazinyl)methanone
(2S,3R,4S,5R,6R)-3,5-dihydroxy-6-[[(3R,5R,8R,9S,10S,13S,14S,17S)-17-[(1S)-1-hydroxyethyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-sulfooxyoxane-2-carboxylic acid
methyl 4-[(1s,2s,17s,19r)-12-hydroxy-8,8,21,21-tetramethyl-5-(3-methylbut-2-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4,6(11),9,12-tetraen-19-yl]-2-methylbut-2-enoate
9-{2-hydroxy-3-[(8-hydroxyheptadeca-1,9-dien-4,6-diyn-3-yl)oxy]-3-methylbutoxy}-4-methoxyfuro[3,2-g]chromen-7-one
(1s,2s,17s,19r)-12-hydroxy-19-[(2z)-4-hydroxy-3-methylbut-2-en-1-yl]-17-methoxy-8,8,21,21-tetramethyl-5-(3-methylbut-2-en-1-yl)-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4,6(11),9,12,15-pentaene-14,18-dione
(2e)-4-[(1r,2r,15s,16r,17r,19s)-12-hydroxy-16-methoxy-8,8,21,21-tetramethyl-5-(3-methylbut-2-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4,6(11),9,12-tetraen-19-yl]-2-methylbut-2-enal
(4as,6r,8as)-4,8a-dimethyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl)-1,4a,5,6,7,8-hexahydronaphthalen-2-one
(8s,21s)-16,27-dimethoxy-7,22-dimethyl-14,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.2¹⁰,¹³.1⁴,³⁰.1¹⁵,¹⁹.0³,⁸.0²⁵,³³.0²⁸,³²]heptatriaconta-1(30),2,4(34),10,12,15(35),16,18,25,27,32,36-dodecaene
(8s)-16,27-dimethoxy-7,22-dimethyl-29,31-dioxa-7,22-diazaoctacyclo[19.9.3.1⁴,³⁰.1¹⁰,¹⁴.1¹⁵,¹⁹.0³,⁸.0²⁵,³³.0²⁸,³²]hexatriaconta-1(30),2,4(34),10,12,14(36),15(35),16,18,25,27,32-dodecaen-13-ol
(4ar,6r,8ar)-4,8a-dimethyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl)-1,4a,5,6,7,8-hexahydronaphthalen-2-one
atractyloside i
{"Ingredient_id": "HBIN017309","Ingredient_name": "atractyloside i","Alias": "NA","Ingredient_formula": "C27H44O13","Ingredient_Smile": "CC1=C(C(=O)CC2(C1CC(CC2)C(C)(C)OC3C(C(C(C(O3)CO)O)O)O)C)OC4C(C(C(C(O4)CO)O)O)O","Ingredient_weight": "576.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14425","TCMID_id": "1981","TCMSP_id": "NA","TCM_ID_id": "6485","PubChem_id": "101831407","DrugBank_id": "NA"}